Table: OncoTherapy Science -Q1 group results

OncoTherapy Science

06/08/2021 09:00

Aug 6 (Reuters)- 
             OncoTherapy Science Inc 
             CONSOLIDATED FINANCIAL HIGHLIGHTS 
     (in billions of yen unless specified)                
                 3 months ended      3 months ended       Year to 
                Jun 30, 2021        Jun 30, 2020     Mar 31, 2022 
                   LATEST             YEAR-AGO          LATEST    
                   RESULTS             RESULTS         FORECAST   
  Sales            93 mln              41 mln                     
                (+127.2 pct)         (-26.5 pct)                  
  Operating     loss 571 mln        loss 399 mln                  
  Recurring     loss 571 mln        loss 398 mln                  
  Net           loss 534 mln        loss 318 mln                  
  EPS           loss 3.00 yen       loss 1.81 yen                 
  Ann Div                                NIL              NIL     
  -Q2 div
  -Q4 div                                NIL              NIL     
  
  NOTE - OncoTherapy Science Inc. 
  To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4564.T